논문KCI 등재
Correspondence on Letter regarding “Toward hepatitis C virus elimination using artificial intelligence”
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
참고문헌 (6)
- Hur MH, "Toward hepatitis C virus elimination using artificial intelligence", Clin Mol Hepatol, 30, pp.147~149 (2024)
- Lu MY, "Artificial intelligence predicts direct-acting antivirals failure among hepatitis C virus patients : A nationwide hepatitis C virus registry program", Clin Mol Hepatol, 30, pp.64~79 (2024)
- Kim KA, "Nextgeneration sequencing analysis of hepatitis C virus resistanceassociated substitutions in direct-acting antiviral failure in South Korea", Clin Mol Hepatol, 29, pp.496~509 (2023)
- Huang CF, "An open-label, randomized, active-controlled trial of 8 versus 12 weeks of elbasvir", grazoprevir for treatment-naive patients with chronic hepatitis C genotype 1b infection and mild fibrosis(EGALITE Study) : Impact of baseline viral loads and NS5A resistance-associated substitutions, 2019, pp.220, 557~566
- Huang CF, "Host interleukin-28B genetic variants versus viral kinetics in determining responses to standard-of-care for Asians with hepatitis C genotype 1", Antiviral Res, 93, pp.239~244 (2012)
- Lu MY, "Elevated on-treatment levels of serum IFN-gamma is associated with treatment failure of peginterferon plus ribavirin therapy for chronic hepatitis C", Sci Rep, 6, pp.22995~ (2016)
관련 논문AI추천
Toward hepatitis C virus elimination using artificial intelligenceJeong-Hoon Lee, Moon Haeng Hur대한간학회 · Clinical and Molecular Hepatology2024 · 제30권 제2호Correspondence to editorial on “Adverse impact of metabolic dysfunction on fibrosis regression following direct-acting antiviral therapy: A multicenter study for chronic hepatitis C”Jae Young Jang, Seung Up Kim, Tom Ryu, Young Chang대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제2호Correspondence to editorial on “Core indicators related to the elimination of hepatitis B and C virus infection in South Korea: A nationwide study”Chang Hun Lee, In Hee Kim, Sook-Hyang Jeong대한간학회 · Clinical and Molecular Hepatology2024 · 제30권 제4호Letter to the editor on “Direct-acting antiviral therapy for patients with HCV-related hepatocellular carcino ma: a nationwide cohort study”Deyan Chen, Fuliang Chen, Qiong Wang, Xiaodi Yang, Xiaojing Wang, Zhongqing Qian대한간학회 · Clinical and Molecular Hepatology2026 · 제32권 제1호Reply to correspondence on “Adverse impact of metabolic dysfunction on fibrosis regression following direct- acting antiviral therapy: A multicenter study for chronic hepatitis C”Chen-Hua Liu, Yu-Ping Chang대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제2호HCV self-testing: Bridging screening gaps and ensuring cost-effectiveness for both high-risk and universal populations: Correspondence to editorial on “Selftesting strategy to eliminate hepatitis C as per World Health Organization’s goal: Analysis of disease burden and cost-effectiveness”Beom Kyung Kim, Gyeongseon Shin, Hankil Lee, Sang Hoon Ahn, SeungJin Bae대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제2호
이 간행물의 다른 논문 (31건)
Comprehensive approach to controlling chronic hepatitis B in ChinaJidong Jia, Shan Shan, Xinyan Zhaopp. 135-143Cardiovascular risk of tenofovir disoproxil fumarate or tenofovir alafenamide in patients with chronic hepatitis B: More questions than an answerMing-Lung Yu, Pin-Nan Chengpp. 144-146Toward hepatitis C virus elimination using artificial intelligenceJeong-Hoon Lee, Moon Haeng Hurpp. 147-149Starting the journey: Understanding the roles of complement proteins in liver diseases through mendelian randomizationJu Dong Yang, Mohammad Saeid Rezaee-Zavareh, Naomy Kimpp. 150-153Enhancing off-nucleos(t)ide analogue outcome predictions in chronic hepatitis B with time-varying hepatitis B core-related antigenChen-Te Huang, Tai-Chung Tsengpp. 154-156